Pharmaceutical Investment Oversight and Accountability Act

The Pharmaceutical Investment Oversight and Accountability Act requires the Federal Trade Commission to produce an annual report on foreign investment within the U.S. pharmaceutical industry. This report must assess how foreign ownership affects domestic drug manufacturing, supply chains, and the capacity to sequence or store DNA. The FTC will also review past investigations into these foreign transactions to determine how many were approved or blocked. Finally, the agency must publish a public summary of its findings on its website and share the full report with specific congressional committees.